UNSPSC 51000000: Pharmaceutical Products incl. Contraceptives and Vaccines

This segment includes natural or synthetic materials and compounds used in the prevention or treatment of disease in humans.

UNSPSC 51000000 Pharmaceutical Products incl. Contraceptives and Vaccines, a Segment code, spans the range of prescription medications, over-the-counter products, vaccines, and related pharmaceutical services that state and local governments procure for public health, emergency medical services, behavioral health, and institutional care. Recent solicitations show state and local buyers purchasing naloxone and drug deactivation systems for community health, BLS/ALS pharmaceuticals and vending systems for fire departments, specialty pharmacy services for developmental centers and clinics, generic multi-source pharmaceuticals through cooperative purchasing, and vaccine administration services—reflecting a broad mix of procurement types across diverse issuing bodies and use cases.

State departments, counties, cities, and special districts all solicit under this code with significant recent activity from California (Orange County, Tuolumne County, Pinellas County), Florida (Seminole County, Pasco County), Arizona (Tucson), Minnesota (through MMCAP cooperative), Rhode Island, Connecticut, and Utah. The County of Orange in California appears as a repeat buyer across multiple pharmaceutical and health service categories. Representative recent opportunities include Seminole County, Florida issuing an IFB on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries (response due July 26, 2023); the City of Tucson Fire Department releasing an RFP on June 24, 2026, for BLS/ALS pharmaceuticals, supplies, and VendNovation vending systems with federal compliance obligations and proposals due the same day; the California Department of Developmental Services issuing an IFB on April 23, 2026, for pharmacy services at a 63-bed state facility with response deadline May 12, 2026; Orange County, California soliciting specialty indoor air quality laboratory analysis services on July 6, 2026, with IFB responses due March 30, 2026 (though this opportunity appears misclassified to the code); and MMCAP issuing an RFP on January 20, 2026, for generic multi-source pharmaceuticals and OTC products across multiple states with proposals due March 26, 2026. Activity concentrates in the West and Southeast, with cooperative purchasing vehicles (MMCAP) and master price agreements (Rhode Island MPA 613 for vaccine administration, January through June 2026) adding significant volume to the segment.